Madam Therapeutics’ is a pre-clinical stage biotech company from the Netherlands that is developing novel antibiotics, so called Synthetic Anti-Microbial and Anti-Biofilm Peptides (SAAPs) to combat a wide variety of (resistant) bacterial infections.
Our SAAPs are inspired on the naturally occurring human defense peptides that guard us from many bugs daily. They are highly active against numerous (multi- and PAN drug resistant) bacteria and have a very favorable tolerance profile. Our SAAPs combine two characteristics essential for such new strategies: they kill bacteria fast (within minutes) and from the outside and they have a limited likelihood of creating resistance themselves. The peptides are effective against a wide range of bacteria including the ones on the WHO priority pathogens list.
Apart from our SAAPs to treat infections in humans, we also develop specific peptides to treat infections in animals.
No action today is no cure tomorrow